Anna Zuk

Company: Akebia Therapeutics Inc

Job title: Senior Scientific Director

Seminars:

Pathophysiology of the AKI to CKD Transition: Understanding Mechanisms of Injury & Disease Progression 2:00 pm

An overview of the AKI-to-CKD transition, highlighting the unmet need through epidemiological insights, patient tracking data, and the challenges in translating preclinical findings to human disease. Exploration of key mechanisms driving maladaptive repair, including cellular senescence, mitochondrial dysfunction, and persistent inflammation that contribute to CKD progression post-AKI. Discussion of clinical development challenges, such as trial…Read more

day: Day One Track 1 PM